epidermal-growth-factor and Developmental-Disabilities

Mutations in the SH3PXD2B gene coding for the Tks4 protein are responsible for the autosomal recessive Frank-ter Haar syndrome. Tks4, a substrate of Src tyrosine kinase, is implicated in the regulation of podosome formation. Here, we report a novel role for Tks4 in the EGF signaling pathway. In EGF-treated cells, Tks4 is tyrosine-phosphorylated and associated with the activated EGF receptor. This association is not direct but requires the presence of Src tyrosine kinase. In addition, treatment of cells with LY294002, an inhibitor of PI 3-kinase, or mutations of the PX domain reduces tyrosine phosphorylation and membrane translocation of Tks4. Furthermore, a PX domain mutant (R43W) Tks4 carrying a reported point mutation in a Frank-ter Haar syndrome patient showed aberrant intracellular expression and reduced phosphoinositide binding. Finally, silencing of Tks4 was shown to markedly inhibit HeLa cell migration in a Boyden chamber assay in response to EGF or serum. Our results therefore reveal a new function for Tks4 in the regulation of growth factor-dependent cell migration.

Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Movement; Chlorocebus aethiops; Chromones; COS Cells; Craniofacial Abnormalities; Developmental Disabilities; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Gene Silencing; Heart Defects, Congenital; HeLa Cells; Humans; Morpholines; Mutation; Osteochondrodysplasias; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Structure, Tertiary; Signal Transduction; src-Family Kinases